Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of serum miR-191-5p, miR-24-3p, miR-128-3p, and miR-376c-3 in multiple sclerosis patients

12 Mar 2018

Abstract excerpt

BACKGROUND: Biomarkers that could be used in early diagnosis of multiple sclerosis (MS), segregation of disease subtypes, and discrimination of the aggressive disease course from the benign one are urgently needed. OBJECTIVE: The aim of this study was to investigate the specificity of circulating microRNAs: miR-191-5p, miR-128-3p, miR-24-3p, and miR-376c-3p in MS and evaluate their association with disease...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Circular RNAs in diseases
Share to MicroRNA in disease regulation
Share to Multiple Sclerosis Research Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29527713
DOI: 10.1111/ane.12921

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of serum miR-191-5p, miR-24-3p, miR-128-3p, and miR-376c-3 in multiple sclerosis patientsPMID 29527713Read ↗

Circulating microRNAs as biomarkers in progressive multiple sclerosisSemantic proximity Read ↗

Temporal variability of serum miR-191, miR-223, miR-128, and miR-24 in multiple sclerosis: A 4-year follow-up studySemantic proximity Read ↗

Identification of MS-specific serum miRNAs in an international multicenter studySemantic proximity Read ↗

miRNA Signature in CSF From Patients With Primary Progressive Multiple SclerosisSemantic proximity Read ↗

Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosisSemantic proximity Read ↗

Circulating MicroRNAs as biomarkers for disease staging in multiple sclerosisSemantic proximity Read ↗

Association between circulating MicroRNAs (hsa-miR-92a-1* and hsa-miR-454) and multiple sclerosis phenotypes and activity status.Semantic proximity Read ↗

Regulated microRNAs in the CSF of patients with multiple sclerosisSemantic proximity Read ↗

Early miR-320b and miR-25-3p miRNA levels correlate with multiple sclerosis severity at 10 years: a cohort studySemantic proximity Read ↗

MicroRNAs in blood and cerebrospinal fluid as diagnostic biomarkers of multiple sclerosis and to monitor disease progressionSemantic proximity Read ↗

CSF microRNAs discriminate MS activity and share similarity to other neuroinflammatory disordersSemantic proximity Read ↗

Altered miR-10, miR-24a, miR-124, and miR-21 Expression in Peripheral Blood Mononuclear Cells of Patients with Multiple SclerosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.